Manufacturing “Hub-and-spoke” drug manufacturing set to benefit from new FDA rule Pharmaceutical TechnologyThe proposed rule would allow multiple manufacturing units at different locations to register as one establishment.Read full story pharminent July 13, 2026 (Last updated: July 15, 2026) Pharmaceutical Technology The proposed rule would allow multiple manufacturing units at different locations to register as one establishment. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: FDA approves MSD’s Keytruda combinations for MIBCNext: FDA posts new rejection letters days after confirming pause Related Stories Manufacturing Lilly and Resilience invest $750M in diabetes and obesity drug device supply pharminent July 31, 2026 Manufacturing GSK Cambridge Move Signals Shift in Drug Scale-Up Strategy pharminent July 29, 2026 Manufacturing GSK to quit Stevenage for new R&D site in Cambridge pharminent July 28, 2026
